Figure 8

Disturbed metabolic pathways implicated in ACS pathogenesis. Five metabolic pathways relating to MDM during the progression from HC to UA and then to AMI are altered: glycerophospholipid metabolism, cysteine and methionine metabolism, valine, leucine and isoleucine biosynthesis, arginine biosynthesis, purine metabolism. Red font indicates the two-serum potential diagnostic metabolites, and the blue indicates the two-urine potential diagnostic metabolites. NP pathway natriuretic peptide pathway, NO pathway nitric oxide pathway.